EditorialAutophagy2022

Susceptibility to autophagy inhibition is enhanced by dual IGF1R and MAPK/ERK inhibition in pancreatic cancer.

DOI 10.1080/15548627.2022.2042782 ↗ OpenAlex, retrieved 5 November 2026

Journal: Autophagy
Published: 24 February 2022
Citations: 17
Type: Editorial

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Grants 3

Defining the contributions of WT RAS in RAS-mutant lung cancer F32CA232529 ↗
Project 1: Overcoming Tumor-Induced Immune Suppression to Improve Responses to Immunotherapy P50CA196510 ↗
Mechanistic dissection and inhibitor targeting of autophagy in RAS driven cancers R37CA251877 ↗